Suppression of adjuvant arthritis in rats with chronic bromocriptine treatment does not prevent associated oxidative stress

International Journal of Immunopathology and Pharmacology

Volumn 13, Issue 1, 2000, Pages 31-37

  Jurcovicova J ^a   Svik K ^b   Rovensky J ^b   Stancikova M ^b   Zorad, S ^a   Konecna I ^c   Holecek V ^c   Trefil, L ^c   Racek, J ^c   Rokyta, R ^c  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adjuvant arthritis; Bromocriptine; Nitric oxide; Oxidative stress; Rat

Indexed keywords

BROMOCRIPTINE; CORTICOSTERONE; MESSENGER RNA; NITRATE; NITRITE; PROLACTIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADENOHYPOPHYSIS; ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; JOINT DESTRUCTION; MALE; NONHUMAN; OXIDATIVE STRESS; PAW EDEMA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RAT; SPLEEN;

EID: 1642602500     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200001300105     Document Type: Article

References (30)

1. Mapp P.I., M.C. Grootveld and D.R. Blake. 1995. Hypoxia, oxidative stress and rheumatoid arthritis. British Med. Bull. 51:419.
2. Murell G.A., D. Jang and R.J. Williams. 1995. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 206:15.
3. Stefanovic-Racic M., K. Meyers, C. Meschter, J.W. Coffey, R.A. Hoffman and C.H. Evans. 1994. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum. 37:1062.
4. Clevenger C.V., A.L. Sillman, J. Hanley-Hyde and M.B. Prystowsky. 1992. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 130:3216.
5. Rovensky J., M. Buc, Z. Lojda, M. Ruzickovà, S. Blazickovà, L'. Rauovà, T. Mistina, M. Vigas and V. Lackovic. 1995. Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch. Immunol. Ther. Exp. (Warsz.) 43:221.
6. Chuang T.T., L. Caccavelli, C. Cordon, and A. Enjalbert. 1983. Protein kinase C regulation of prolactin gene expression in lactotroph cells: Involvement in dopamine inhibition. Endocrinology 132:832.
7. Nagy E., I. Berczi, G.E. Wren, S.L. Asa and K. Kovacs. 1983. Immunomodulation by bromocriptine. Immunopharmacology 6:231.
8. Berczi I., E. Nagy, S.L. Asa and K. Kovacs. 1984. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum. 27:682.
9. Whyte A. and R.O. Williams. 1988. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum. 31:927.
10. Eulry F., H. Mayaudon, D. Lechevalier, B. Bauduceau, L. Ariche, H. Ouakil, P. Crozes and J. Magnin. 1995. Treatment of rheumatoid psoriasis with bromocriptine. Presse Med. 24:1642
11. Figueroa F.E., F. Carrion, M.E. Martinez, S. Rivero and I. Mamani. 1997. Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis. Br. J. Rheumatol. 36:1022
12. Lowry O.H., N.J. Rosenbrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265.
13. Cortas N.K. and N.W Wakid. 1990. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36:1440.
14. Neidhardt M. and E.W. Fluckiger. 1992. Hyperprolactinemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 77:449.
15. Neidhardt M. and D.F. Larson. 1990. Freund's complete adjuvant induces ornithine decarboxylase activity in the central nervous system of male rats and triggers the release of pituitary hormones. J. Neuroimmunol. 26:97.
16. Selgas L., A. Arce, A.I. Esquilino and D.P. Cardinali. 1997. Twenty-four-hour rhythms of serum ACTH, prolactin, growth hormone, and thyroid-stimulating hormone, and of median-eminence norepinephrine, dopamine, and serotonin, in rats injected with Freund's adjuvant. Chronobiol. Int. 14:253.
17. Lopez-Calderon A., C. Ariznavarreta, M.D. Calderon, J.A. Tresguerres and M.I. Gonzales-Quijano. 1989. Role of the adrenal cortex in chronic stress-induced inhibition of prolactin secretion in male rats. J. Endocrinol. 120:269.
18. Vile J.M. and P.G. Strange. 1996. D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes. Biol. Psychiatry 40:881.
19. Neidhart M. 1997. Bromocriptine has little effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed. Pharmacother. 51:118.
20. Morikawa K., F. Oseko and S. Morikawa. 1993. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin. Exp. Immunol. 93:200
21. Morikawa K., F. Oseko and S. Morikawa. 1994. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin. Exp. Immunol. 95:514.
22. Dunn A.J. 1990. Interleukin-1 as a stimulator of hormone secretion (PNEI REVIEW). Prog. Neuro Encocrin. Immunol. 3:26
23. Wilder R.L. 1996. Hormones and autoimmunity: animals model of arthritis. In Baillier's Clinical Rheumatology Neuroendocrine Immune Mechanisms of Rheumatic Diseases. I.C. Chikanza, ed. Bailliere Tindal London, p.259.
24. de Kloet E.R., N.Y. Rots and A.R. Cools. 1996. Brain ñ corticosteroid hormone dialogue: slow and persistent (Review). Cell. Mol. Neurobiol 3:345
25. Tilders F.J. and E.D. Schmidt. 1998. Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness. Ann. N.Y. Acad. Sci. 840:65
26. Ohta Y., M. Yamane, T. Sohda and H. Makino. 1997. TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis. Immunology 92:75
27. Roubenoff R., L.M. Freeman, D.E. Smith, L.W. Abad, C.A. Dinarello and J.J. Kehayias. 1997. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 40:534
28. Nowak D., T. Pietras, A. Antczak, M. Krol and G. Piasecka. 1993. Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice. Antonie Van Leeuwenhoek 63:77
29. Tanaka S., T. Matsui, T. Murakami, T. Ishizuka, M. Sugiura., K. Kawashima and T. Sugita. 1998. Immunological abnormalities associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis. Int. J. Immunopharmacol. 20:71
30. de Mello S.B., G.S. Novaes, I.M. Laurindo, M.N. Muscara, P.M. Maciel and W. Cossermelli. 1997. Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints. Inflamm. Res. 46:72 7